We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/Journals/Alzheimer’s Research & Therapy
Peer ReviewedCC-BY

Alzheimer’s Research & Therapy

Print ISSN

1758-9193

e-ISSN

1758-9193

Country

GB

Language

EN

Founded

2009

Journal Info

Publisher

BMC

50

Articles

0

Volumes

Published Works

Recent Articles

View all →
Article

Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants

Bruno Dubois, Christine A. F. Von Arnim, Nerida Burnie

Vol. 15, No. 120230
Article

Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice

Matthew J. Simon, Marie Xun Wang, Ozama Ismail

Vol. 14, No. 120220
Article

Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

Eric McDade, Jeffrey L. Cummings, Shobha Dhadda

Vol. 14, No. 120220
Article

Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer’s disease dementia: a systematic review

Sergio Grueso, Raquel Viejo-Sobera

Vol. 13, No. 120210
Article

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Chad J. Swanson, Yong Zhang, Shobha Dhadda

Vol. 13, No. 120210
Article

Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease

Matthew C. L. Phillips, Laura Deprez, Grace M. N. Mortimer

Vol. 13, No. 120210
Article

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

Claudia Cicognola, Shorena Janelidze, Joakim Hertze

Vol. 13, No. 120210
Article

Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach

Alzheimer's Disease Neuroimaging Initiative, Sarah K. Royse, Davneet Singh Minhas

Vol. 13, No. 120210
Article

Cognitive impact of COVID-19: looking beyond the short term

James Scott Miners, Patrick G. Kehoe, Seth Love

Vol. 12, No. 120200
Article

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Michael Thomas Heneka, Douglas Taylor Golenbock, Eicke Latz

Vol. 12, No. 120200
Article

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval

Martin Tolar, Susan R. Abushakra, John A. Hey

Vol. 12, No. 120200
Article

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

the Synaptic Health Endpoints Working Group, Martí Colom‐Cadena, Tara L. Spires‐Jones

Vol. 12, No. 120200